0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Faecal Microbiota Transplant(FMT) Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-37X12867
Home | Market Reports | Health| Health Conditions
Global Faecal Microbiota Transplant FMT Therapy Market Research Report 2023
BUY CHAPTERS

Faecal Microbiota Transplant(FMT) Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-37X12867
Report
October 2024
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Faecal Microbiota Transplant(FMT) Therapy - Market Size

Therapy was estimated to be worth US$ 1782 million in 2023 and is forecast to a readjusted size of US$ 2497 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030

Faecal Microbiota Transplant(FMT) Therapy - Market

Faecal Microbiota Transplant(FMT) Therapy - Market

The global market for Faecal Microbiota Transplant(FMT)
North American market for Faecal Microbiota Transplant(FMT) Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Faecal Microbiota Transplant(FMT) Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Faecal Microbiota Transplant(FMT) Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Faecal Microbiota Transplant(FMT) Therapy include Enterome Bioscience, Rebiotix, Ritter Pharmaceuticals, Finch Therapeutics, Crestovo, Maat Pharma, Seres Therapeutics, Second Genome and OpenBiome, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Faecal Microbiota Transplant(FMT) Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Faecal Microbiota Transplant(FMT) Therapy by region & country, by Type, and by Application.
The Faecal Microbiota Transplant(FMT) Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Faecal Microbiota Transplant(FMT) Therapy.
Market Segmentation

Scope of Faecal Microbiota Transplant(FMT) Therapy - Market Report

Report Metric Details
Report Name Faecal Microbiota Transplant(FMT) Therapy - Market
Forecasted market size in 2030 US$ 2497 million
CAGR 4.9%
Forecasted years 2024 - 2030
Segment by Type:
  • Oral
  • Enema
Segment by Application
  • Clostridioides Difficile Infection(CDI)
  • Digestive System Disease
  • Nervous System Disease
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Enterome Bioscience, Rebiotix, Ritter Pharmaceuticals, Finch Therapeutics, Crestovo, Maat Pharma, Seres Therapeutics, Second Genome, OpenBiome, MicroBiome Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Faecal Microbiota Transplant(FMT) Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Faecal Microbiota Transplant(FMT) Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Faecal Microbiota Transplant(FMT) Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Faecal Microbiota Transplant(FMT) Therapy - Market size in 2030?

Ans: The Faecal Microbiota Transplant(FMT) Therapy - Market size in 2030 will be US$ 2497 million.

Who are the main players in the Faecal Microbiota Transplant(FMT) Therapy - Market report?

Ans: The main players in the Faecal Microbiota Transplant(FMT) Therapy - Market are Enterome Bioscience, Rebiotix, Ritter Pharmaceuticals, Finch Therapeutics, Crestovo, Maat Pharma, Seres Therapeutics, Second Genome, OpenBiome, MicroBiome Therapeutics

What are the Application segmentation covered in the Faecal Microbiota Transplant(FMT) Therapy - Market report?

Ans: The Applications covered in the Faecal Microbiota Transplant(FMT) Therapy - Market report are Clostridioides Difficile Infection(CDI), Digestive System Disease, Nervous System Disease, Others

What are the Type segmentation covered in the Faecal Microbiota Transplant(FMT) Therapy - Market report?

Ans: The Types covered in the Faecal Microbiota Transplant(FMT) Therapy - Market report are Oral, Enema

1 Market Overview
1.1 Faecal Microbiota Transplant(FMT) Therapy Product Introduction
1.2 Global Faecal Microbiota Transplant(FMT) Therapy Market Size Forecast
1.3 Faecal Microbiota Transplant(FMT) Therapy Market Trends & Drivers
1.3.1 Faecal Microbiota Transplant(FMT) Therapy Industry Trends
1.3.2 Faecal Microbiota Transplant(FMT) Therapy Market Drivers & Opportunity
1.3.3 Faecal Microbiota Transplant(FMT) Therapy Market Challenges
1.3.4 Faecal Microbiota Transplant(FMT) Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Faecal Microbiota Transplant(FMT) Therapy Players Revenue Ranking (2023)
2.2 Global Faecal Microbiota Transplant(FMT) Therapy Revenue by Company (2019-2024)
2.3 Key Companies Faecal Microbiota Transplant(FMT) Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Faecal Microbiota Transplant(FMT) Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of Faecal Microbiota Transplant(FMT) Therapy
2.6 Faecal Microbiota Transplant(FMT) Therapy Market Competitive Analysis
2.6.1 Faecal Microbiota Transplant(FMT) Therapy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Faecal Microbiota Transplant(FMT) Therapy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Faecal Microbiota Transplant(FMT) Therapy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Enema
3.2 Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type
3.2.1 Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Faecal Microbiota Transplant(FMT) Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Faecal Microbiota Transplant(FMT) Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clostridioides Difficile Infection(CDI)
4.1.2 Digestive System Disease
4.1.3 Nervous System Disease
4.1.4 Others
4.2 Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application
4.2.1 Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Faecal Microbiota Transplant(FMT) Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Faecal Microbiota Transplant(FMT) Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Region
5.1.1 Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Region (2019-2024)
5.1.3 Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Region (2025-2030)
5.1.4 Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Faecal Microbiota Transplant(FMT) Therapy Sales Value, 2019-2030
5.2.2 North America Faecal Microbiota Transplant(FMT) Therapy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Faecal Microbiota Transplant(FMT) Therapy Sales Value, 2019-2030
5.3.2 Europe Faecal Microbiota Transplant(FMT) Therapy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Faecal Microbiota Transplant(FMT) Therapy Sales Value, 2019-2030
5.4.2 Asia Pacific Faecal Microbiota Transplant(FMT) Therapy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Faecal Microbiota Transplant(FMT) Therapy Sales Value, 2019-2030
5.5.2 South America Faecal Microbiota Transplant(FMT) Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Sales Value, 2019-2030
5.6.2 Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Faecal Microbiota Transplant(FMT) Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Faecal Microbiota Transplant(FMT) Therapy Sales Value
6.3 United States
6.3.1 United States Faecal Microbiota Transplant(FMT) Therapy Sales Value, 2019-2030
6.3.2 United States Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Faecal Microbiota Transplant(FMT) Therapy Sales Value, 2019-2030
6.4.2 Europe Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Faecal Microbiota Transplant(FMT) Therapy Sales Value, 2019-2030
6.5.2 China Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Faecal Microbiota Transplant(FMT) Therapy Sales Value, 2019-2030
6.6.2 Japan Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Faecal Microbiota Transplant(FMT) Therapy Sales Value, 2019-2030
6.7.2 South Korea Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Faecal Microbiota Transplant(FMT) Therapy Sales Value, 2019-2030
6.9.2 India Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Enterome Bioscience
7.1.1 Enterome Bioscience Profile
7.1.2 Enterome Bioscience Main Business
7.1.3 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
7.1.4 Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Revenue (US$ Million) & (2019-2024)
7.1.5 Enterome Bioscience Recent Developments
7.2 Rebiotix
7.2.1 Rebiotix Profile
7.2.2 Rebiotix Main Business
7.2.3 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
7.2.4 Rebiotix Faecal Microbiota Transplant(FMT) Therapy Revenue (US$ Million) & (2019-2024)
7.2.5 Rebiotix Recent Developments
7.3 Ritter Pharmaceuticals
7.3.1 Ritter Pharmaceuticals Profile
7.3.2 Ritter Pharmaceuticals Main Business
7.3.3 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
7.3.4 Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Revenue (US$ Million) & (2019-2024)
7.3.5 Finch Therapeutics Recent Developments
7.4 Finch Therapeutics
7.4.1 Finch Therapeutics Profile
7.4.2 Finch Therapeutics Main Business
7.4.3 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
7.4.4 Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue (US$ Million) & (2019-2024)
7.4.5 Finch Therapeutics Recent Developments
7.5 Crestovo
7.5.1 Crestovo Profile
7.5.2 Crestovo Main Business
7.5.3 Crestovo Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
7.5.4 Crestovo Faecal Microbiota Transplant(FMT) Therapy Revenue (US$ Million) & (2019-2024)
7.5.5 Crestovo Recent Developments
7.6 Maat Pharma
7.6.1 Maat Pharma Profile
7.6.2 Maat Pharma Main Business
7.6.3 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
7.6.4 Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Revenue (US$ Million) & (2019-2024)
7.6.5 Maat Pharma Recent Developments
7.7 Seres Therapeutics
7.7.1 Seres Therapeutics Profile
7.7.2 Seres Therapeutics Main Business
7.7.3 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
7.7.4 Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue (US$ Million) & (2019-2024)
7.7.5 Seres Therapeutics Recent Developments
7.8 Second Genome
7.8.1 Second Genome Profile
7.8.2 Second Genome Main Business
7.8.3 Second Genome Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
7.8.4 Second Genome Faecal Microbiota Transplant(FMT) Therapy Revenue (US$ Million) & (2019-2024)
7.8.5 Second Genome Recent Developments
7.9 OpenBiome
7.9.1 OpenBiome Profile
7.9.2 OpenBiome Main Business
7.9.3 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
7.9.4 OpenBiome Faecal Microbiota Transplant(FMT) Therapy Revenue (US$ Million) & (2019-2024)
7.9.5 OpenBiome Recent Developments
7.10 MicroBiome Therapeutics
7.10.1 MicroBiome Therapeutics Profile
7.10.2 MicroBiome Therapeutics Main Business
7.10.3 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
7.10.4 MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Revenue (US$ Million) & (2019-2024)
7.10.5 MicroBiome Therapeutics Recent Developments
8 Industry Chain Analysis
8.1 Faecal Microbiota Transplant(FMT) Therapy Industrial Chain
8.2 Faecal Microbiota Transplant(FMT) Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Faecal Microbiota Transplant(FMT) Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Faecal Microbiota Transplant(FMT) Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Faecal Microbiota Transplant(FMT) Therapy Market Trends
    Table 2. Faecal Microbiota Transplant(FMT) Therapy Market Drivers & Opportunity
    Table 3. Faecal Microbiota Transplant(FMT) Therapy Market Challenges
    Table 4. Faecal Microbiota Transplant(FMT) Therapy Market Restraints
    Table 5. Global Faecal Microbiota Transplant(FMT) Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Faecal Microbiota Transplant(FMT) Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Faecal Microbiota Transplant(FMT) Therapy Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Faecal Microbiota Transplant(FMT) Therapy Product Type
    Table 9. Key Companies Time to Begin Mass Production of Faecal Microbiota Transplant(FMT) Therapy
    Table 10. Global Faecal Microbiota Transplant(FMT) Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Faecal Microbiota Transplant(FMT) Therapy as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Faecal Microbiota Transplant(FMT) Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Faecal Microbiota Transplant(FMT) Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Faecal Microbiota Transplant(FMT) Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Faecal Microbiota Transplant(FMT) Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Region (2019-2024) & (%)
    Table 27. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Faecal Microbiota Transplant(FMT) Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Faecal Microbiota Transplant(FMT) Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Faecal Microbiota Transplant(FMT) Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 31. Enterome Bioscience Basic Information List
    Table 32. Enterome Bioscience Description and Business Overview
    Table 33. Enterome Bioscience Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Faecal Microbiota Transplant(FMT) Therapy Business of Enterome Bioscience (2019-2024)
    Table 35. Enterome Bioscience Recent Developments
    Table 36. Rebiotix Basic Information List
    Table 37. Rebiotix Description and Business Overview
    Table 38. Rebiotix Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Faecal Microbiota Transplant(FMT) Therapy Business of Rebiotix (2019-2024)
    Table 40. Rebiotix Recent Developments
    Table 41. Ritter Pharmaceuticals Basic Information List
    Table 42. Ritter Pharmaceuticals Description and Business Overview
    Table 43. Ritter Pharmaceuticals Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Faecal Microbiota Transplant(FMT) Therapy Business of Ritter Pharmaceuticals (2019-2024)
    Table 45. Ritter Pharmaceuticals Recent Developments
    Table 46. Finch Therapeutics Basic Information List
    Table 47. Finch Therapeutics Description and Business Overview
    Table 48. Finch Therapeutics Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Faecal Microbiota Transplant(FMT) Therapy Business of Finch Therapeutics (2019-2024)
    Table 50. Finch Therapeutics Recent Developments
    Table 51. Crestovo Basic Information List
    Table 52. Crestovo Description and Business Overview
    Table 53. Crestovo Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Faecal Microbiota Transplant(FMT) Therapy Business of Crestovo (2019-2024)
    Table 55. Crestovo Recent Developments
    Table 56. Maat Pharma Basic Information List
    Table 57. Maat Pharma Description and Business Overview
    Table 58. Maat Pharma Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Faecal Microbiota Transplant(FMT) Therapy Business of Maat Pharma (2019-2024)
    Table 60. Maat Pharma Recent Developments
    Table 61. Seres Therapeutics Basic Information List
    Table 62. Seres Therapeutics Description and Business Overview
    Table 63. Seres Therapeutics Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Faecal Microbiota Transplant(FMT) Therapy Business of Seres Therapeutics (2019-2024)
    Table 65. Seres Therapeutics Recent Developments
    Table 66. Second Genome Basic Information List
    Table 67. Second Genome Description and Business Overview
    Table 68. Second Genome Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Faecal Microbiota Transplant(FMT) Therapy Business of Second Genome (2019-2024)
    Table 70. Second Genome Recent Developments
    Table 71. OpenBiome Basic Information List
    Table 72. OpenBiome Description and Business Overview
    Table 73. OpenBiome Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Faecal Microbiota Transplant(FMT) Therapy Business of OpenBiome (2019-2024)
    Table 75. OpenBiome Recent Developments
    Table 76. MicroBiome Therapeutics Basic Information List
    Table 77. MicroBiome Therapeutics Description and Business Overview
    Table 78. MicroBiome Therapeutics Faecal Microbiota Transplant(FMT) Therapy Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Faecal Microbiota Transplant(FMT) Therapy Business of MicroBiome Therapeutics (2019-2024)
    Table 80. MicroBiome Therapeutics Recent Developments
    Table 81. Key Raw Materials Lists
    Table 82. Raw Materials Key Suppliers Lists
    Table 83. Faecal Microbiota Transplant(FMT) Therapy Downstream Customers
    Table 84. Faecal Microbiota Transplant(FMT) Therapy Distributors List
    Table 85. Research Programs/Design for This Report
    Table 86. Key Data Information from Secondary Sources
    Table 87. Key Data Information from Primary Sources
    Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Faecal Microbiota Transplant(FMT) Therapy Product Picture
    Figure 2. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Faecal Microbiota Transplant(FMT) Therapy Report Years Considered
    Figure 5. Global Faecal Microbiota Transplant(FMT) Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Faecal Microbiota Transplant(FMT) Therapy Revenue in 2023
    Figure 7. Faecal Microbiota Transplant(FMT) Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Oral Picture
    Figure 9. Enema Picture
    Figure 10. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Clostridioides Difficile Infection(CDI)
    Figure 13. Product Picture of Digestive System Disease
    Figure 14. Product Picture of Nervous System Disease
    Figure 15. Product Picture of Others
    Figure 16. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Faecal Microbiota Transplant(FMT) Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Faecal Microbiota Transplant(FMT) Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Faecal Microbiota Transplant(FMT) Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Faecal Microbiota Transplant(FMT) Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Faecal Microbiota Transplant(FMT) Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Faecal Microbiota Transplant(FMT) Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Faecal Microbiota Transplant(FMT) Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Faecal Microbiota Transplant(FMT) Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Faecal Microbiota Transplant(FMT) Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Faecal Microbiota Transplant(FMT) Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Faecal Microbiota Transplant(FMT) Therapy Sales Value (%), (2019-2030)
    Figure 29. United States Faecal Microbiota Transplant(FMT) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Faecal Microbiota Transplant(FMT) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Faecal Microbiota Transplant(FMT) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Faecal Microbiota Transplant(FMT) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Faecal Microbiota Transplant(FMT) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Faecal Microbiota Transplant(FMT) Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Faecal Microbiota Transplant(FMT) Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Faecal Microbiota Transplant(FMT) Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 50. Faecal Microbiota Transplant(FMT) Therapy Industrial Chain
    Figure 51. Faecal Microbiota Transplant(FMT) Therapy Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Adult Malignant Glioma Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-12R14095
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Add to Cart

Acute Viral Rhinosinusitis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-20P14158
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Diagnosing Fungal Infections - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-23M12935
Wed Nov 06 00:00:00 UTC 2024

Add to Cart